Trial intelligence / Profile preview

Nitric Oxide Effect on Gingival Microcirculation

NCT03605095Completed

Sponsor
Semmelweis University
Start
Jul 2018
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Trial of nitroglycerin (2 arms), sponsored by Semmelweis University. Primary endpoint: Blood flow change after application of NO agonist. Started Jul 2018; status: completed.

02

Drugs

nitroglycerin

Beyond the preview

Go deeper on NCT03605095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03605095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call